Myocardial infarction: Redefined or reinvented?

Heart

Volumn 88, Issue 1, 2002, Pages 1-3

  Dargie, Henry ^a  

^a British Junior Cardiac Association   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; CREATINE KINASE; FIBRINOGEN RECEPTOR ANTAGONIST; TROPONIN;

BLOOD CLOT LYSIS; CLINICAL FEATURE; CLINICAL PRACTICE; CREATINE KINASE BLOOD LEVEL; DISEASE CLASSIFICATION; DRUG INDICATION; ELECTROCARDIOGRAM; HEART INFARCTION; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SHORT SURVEY; TREATMENT INDICATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0036087786     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.1.1     Document Type: Short Survey

References (10)

1. Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology
2. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
3. The prognostic value of toponin T in unstable angina
4. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST segment elevation
5. ACC/AHA guidelines for the management of patients with unstable angina and non ST segment elevation myocardial infarction: Executive summary and recommendations
6. Guideline for the management of patients with acute coronary syndromes without persistent ST segment elevation
7. Acute coronary syndrome without ST elevation: Implementation of new guidelines
8. It's time for a change to troponin standard
9. National Academy for Clinical Biochemistry Standards of Laboratory Practise: Recommendations for the use of cardiac merkers in coronary artery disease